Press Release Verra Mobility Announces Fourth Quarter and Full Year 2025 Financial Results 24 February 2026
Press Release Johnson & Johnson seeks FDA approval of IMAAVY® (nipocalimab-aahu) as the first-ever FDA-approved treatment for warm autoimmune hemolytic anemia (wAIHA) 24 February 2026
Press Release Revolve Group Announces Fourth Quarter and Full Year 2025 Financial Results 24 February 2026
Press Release Workday Announces Fiscal 2026 Fourth Quarter and Full Year Financial Results 24 February 2026
Press Release Neurocrine Biosciences to Present at Upcoming Investor Conferences in March 24 February 2026
